Clinical trial Recruiting at 1 site Interventional Ages 18 and up Women only

Comparing brain activity in women with chronic pain and opioid use to healthy women

Official title: Neurobiological Consequences of Long-Term Opioid Therapy in the Brain and Spinal Cord

Run by Duke University · NCT05905419 · Data updated 2026-11-12

This study looks at how brain activity differs between women with chronic pain and opioid use and healthy women to help find better treatments for pain.

More Opioid Use trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment140 (estimated)
SponsorDuke University
Academic / other
Locations1 site (Durham, North Carolina)
StatusRecruiting
StartedJune 1, 2023
Main results expectedJune 30, 2027
Study endsJune 30, 2027
Registry record updatedJune 3, 2026
Trial IDNCT05905419 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include women aged 18 and older with chronic pain conditions like fibromyalgia or those currently using opioids.

Probably not a fit

Patients who are male or do not have chronic pain or opioid use may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to investigate the differences in brain activity between female adults suffering from chronic pain and/or using opioids and healthy female adults. It employs neuroimaging techniques such as MRI and fMRI, alongside behavioral tasks, sensory testing, blood draws, and questionnaires to gather comprehensive data. The goal is to identify neurophysiological and behavioral variations that could inform the development of targeted treatments for chronic pain and alternatives to opioid therapy. The data will be analyzed using specialized software for neuroimaging and standard statistical methods for other assessments.

Why it matters

Potential benefit: If successful, this study could lead to new, targeted treatments for chronic pain that reduce reliance on opioids.

How similar studies have gone: Other studies have shown promise in using neuroimaging to understand chronic pain, but this specific approach focusing on opioid phases is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria for Healthy Controls:

1. female and ages 18+
2. ability to read/understand English and give consent to participate
3. no current or history of chronic pain
4. not regularly taking any pain-relieving or mood-altering medications (per PI discretion)
5. absence of use of opioid medications

Inclusion Criteria for Individuals with Chronic Pain:

1. female and ages 18 +
2. ability to read/understand English and give consent to participate
3. self-reported or physician diagnosis of fibromyalgia and/or chronic pain
4. current use of opioid medication(s) for inclusion in the opioid patient group -OR- absence of use of opioid medications for inclusion in the non-opioid patient group

Exclusion Criteria (for both groups):

1. limited ability to participate fully in behavioral tasks, longitudinal follow-up
2. MRI contraindication
3. any factors that at the discretion of the investigators would adversely affect the participant or the integrity of the study
4. male

Where it's running

  • Duke University Medical Center
    Durham, North Carolina, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.